Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Vijai Simha"'
Publikováno v:
European Medical Journal Urology (2023)
A 44-year-old otherwise healthy male who had undergone left high inguinal orchidectomy, with histopathology suggestive of classical seminoma, was referred to the authors’ oncology centre for evaluation of persistently deranged renal function tests
Externí odkaz:
https://doaj.org/article/94ce99e7003d4be18250e9ba762d2c7f
Autor:
Prabhat G. Bhargava, Amit Kumar, Vijai Simha, Minit Shah, Shraddha Patkar, Mahesh Goel, Vikas Ostwal, Anant Ramaswamy
Publikováno v:
South Asian Journal of Cancer, Vol 09, Iss 04, Pp 209-212 (2020)
Background Biliary tract cancers (BTCs) are a rare group of cancers with limited data with respect to advanced unresectable cholangiocarcinoma (CCA). Materials and Methods The study is a retrospective study of patients with advanced unresectable/meta
Externí odkaz:
https://doaj.org/article/5a844dc735ed4201895d958904ebfaf6
Autor:
Vijay M. Patil, Arti Bhelekar, Nandini Menon, Atanu Bhattacharjee, Vijai Simha, Ram Abhinav, Anuja Abhyankar, Epari Sridhar, Abhishek Mahajan, Ameya D. Puranik, Nilendu Purandare, Amit Janu, Ankita Ahuja, Rahul Krishnatry, Tejpal Gupta, Rakesh Jalali
Publikováno v:
Cancer Medicine, Vol 9, Iss 13, Pp 4676-4685 (2020)
Abstract Background Relapsed high‐grade glioma has dismal outcomes. Mebendazole has shown promising activity against glioma in in‐vitro and in‐vivo studies. Hence, we undertook a phase 1 study to repurpose mebendazole in the treatment of gliobl
Externí odkaz:
https://doaj.org/article/d0d509fdcef449d0816d5a6561a55a02
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 131-133 (2020)
Externí odkaz:
https://doaj.org/article/2f9d2840549b406c8cdd47be713888a3
Autor:
Vijay M Patil, Amit Joshi, Vanita Noronha, Vikas Talreja, Vijai Simha, Sachin Dhumal, Bhavesh Bandekar, Arun Chandrasekharan, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 3, Pp 173-177 (2019)
Introduction: Nasopharyngeal carcinoma is a rare malignancy. We conducted an audit of systemic therapies received in palliative setting in carcinoma nasopharynx and studied their outcomes. Methods: Patients who underwent first-line palliative systemi
Externí odkaz:
https://doaj.org/article/66fca4b1929c4799ac0af3172c82e053
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 172-181 (2019)
Esophageal cancer is an aggressive disease with high mortality and morbidity. Many of the patients present in advanced stages. In such a situation, systemic therapies are the mainstay of therapy both for palliation of symptoms and for meaningful impr
Externí odkaz:
https://doaj.org/article/29650b33b32942578f99c722a367b6d8
Autor:
Abhishek Mahajan, Hasmukh Jain, Vijai Simha, Tanvi Vaidya, G V Santhosh Kumar, Anurag Gupta, Bhausaheb Bagal, Manju Sengar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 1, Pp 28-33 (2019)
Background and Purpose: Subacute leukoencephalopathy in ALL is a rare complication after high dose methotrexate (HDMTX) administration and recognizing this self-remitting entity has important therapeutic implications. We did a retrospective study to
Externí odkaz:
https://doaj.org/article/07d5fa636df94e1bbe562aed6790026a
Autor:
Vijay Patil, ProfDM, Vanita Noronha, ProfDM, Sachin Babanrao Dhumal, BHMS, Amit Joshi, ProfDM, Nandini Menon, DNB, Atanu Bhattacharjee, PhD, Suyash Kulkarni, ProfMD, Suman Kumar Ankathi, MD, Abhishek Mahajan, ProfMD, Nilesh Sable, ProfMD, Kavita Nawale, MBA, Arti Bhelekar, MSc, Sadaf Mukadam, MSc, Arun Chandrasekharan, DM, Sudeep Das, DM, Dilip Vallathol, DM, Hollis D'Souza, DM, Amit Kumar, DM, Amit Agrawal, MD, Satvik Khaddar, MD, Narmadha Rathnasamy, MD, Ramnath Shenoy, MD, Lakhan Kashyap, MD, Rahul Kumar Rai, MD, George Abraham, MD, Saswata Saha, MD, Swaratika Majumdar, DM, Naveen Karuvandan, MD, Vijai Simha, DM, Vasu Babu, MD, Prahalad Elamarthi, MD, Annu Rajpurohit, MD, Kanteti Aditya Pavan Kumar, MD, Anne Srikanth, MD, Rahul Ravind, MD, Shripad Banavali, ProfMD, Kumar Prabhash, ProfDM
Publikováno v:
The Lancet Global Health, Vol 8, Iss 9, Pp e1213-e1222 (2020)
Summary: Background: Regimens for palliation in patients with head and neck cancer recommended by the US National Comprehensive Cancer Network (NCCN) have low applicability (less than 1–3%) in low-income and middle-income countries (LMICs) because
Externí odkaz:
https://doaj.org/article/ce6b479a469a438f885b09f2ba335a2f
Autor:
Jyoti Bajpai, Arun Chandrasekharan, Vijai Simha, Vikas Talreja, Ashay Karpe, Nikihil Pandey, Ashish Singh, Bharat Rekhi, Tushar Vora, Jaya Ghosh, Shripad Banavali, Sudeep Gupta
Publikováno v:
Journal of Global Oncology, Vol 4, Iss 1, Pp 1-10 (2018)
Purpose: Metastatic osteosarcoma is largely treated with high-dose methotrexate (HDMTX)–based therapy, especially in the pediatric population. This mandates complex pharmacokinetic monitoring in a costly inpatient setting to mitigate unpredictable
Externí odkaz:
https://doaj.org/article/3a7fc9ced0f94eb88a8064bab53fc2f9
Autor:
Anant Ramaswamy, Vikas Ostwal, Kushal Gupta, Vijai Simha, Anup Toshniwal, Nitin Shetty, Chaitali Nashikkar, Sarika Mandavkar, Sudeep Gupta
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 4, Pp 219-222 (2018)
Background: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). Materials and Methods: Patients diagnosed with AGC, receiving biweekly mFOLFIRI
Externí odkaz:
https://doaj.org/article/f4e59f2999684efba7097bc02b4e1408